Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Medi Club Georgia | Healthcare Services | 19.2% | 76th pct | 268 |
| Academician Vakhtang Bo… | Healthcare Services | 17.7% | 73rd pct | 268 |
| S. Khechinashvili Unive… | Healthcare Services | 6.9% | 41st pct | 268 |
| Tbilisi Central Hospital | Healthcare Services | -2.2% | 22nd pct | 268 |
| Jerarsi | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 5 peers filed FY2024. Switch to FY2023 (5 of 5).
| Ratio — FY 2024 | Academician Vakhtang Bo… | Medi Club Georgia | S. Khechinashvili Unive… | Tbilisi Central Hospital | Jerarsi |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 79.9% | 33.2% | 76.0% | 13.9% | — |
| EBITDA Margin | 17.7% | 19.2% | 6.9% | -2.2% | — |
| EBITDAR | 4,938 | 4,910 | 1,758 | -532 | — |
| EBITDAR Margin | 17.7% | 19.2% | 6.9% | -2.2% | — |
| EBIT Margin | 9.4% | 17.9% | 2.6% | -2.6% | — |
| Net Profit Margin | 8.7% | 15.1% | 0.5% | -6.0% | — |
| Operating Expense % of Sales | 62.8% | 14.9% | 70.3% | 16.0% | — |
| Returns | |||||
| Return on Assets (ROA) | 10.8% | 25.1% | 0.7% | -5.1% | — |
| Return on Equity (ROE) | 14.1% | 28.2% | 3.5% | -9.8% | — |
| ROIC [EBIT / Invested Capital] | |||||
| 14.6% |
| 46.3% |
| 6.8% |
| -2.7% |
| — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 13.2% | 0.0% | 34.1% | 29.8% | — |
| Debt-to-Equity | 0.17x | 0.00x | 1.59x | 0.58x | — |
| Debt-to-EBITDA | 0.60x | 0.00x | 3.44x | N/A | — |
| Equity-to-Assets | 76.2% | 88.9% | 21.4% | 51.7% | — |
| Net Debt | 846 | -3,756 | 6,014 | 8,706 | — |
| Cash & Equivalents | 2,134 | 3,756 | 36 | 75 | — |
| Total Debt | 2,981 | N/A | 6,050 | 8,781 | — |
| Liquidity & working capital | |||||
| Current Ratio | 3.28x | 3.81x | 0.60x | 0.95x | — |
| Quick Ratio | 2.93x | 3.15x | 0.53x | 0.82x | — |
| Cash Ratio | 0.78x | 2.20x | 0.00x | 0.01x | — |
| Total Current Assets | 8,973 | 6,509 | 5,902 | 9,815 | — |
| Total Current Liabilities | 2,735 | 1,710 | 9,787 | 10,386 | — |
| Inventory | 957 | 1,130 | 672 | 1,296 | — |
| Trade Receivables | 5,882 | 1,514 | 5,195 | 8,444 | — |
| Trade Payables | 2,389 | 518 | 6,962 | 5,468 | — |
| Net Working Capital | 6,238 | 4,799 | -3,885 | -571 | — |
| Net Working Capital % of Revenue | 22.3% | 18.8% | -15.2% | -2.3% | — |
| Trade Working Capital | 4,449 | 2,126 | -1,096 | 4,272 | — |
| Trade Working Capital % of Revenue | 15.9% | 8.3% | -4.3% | 17.3% | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | — |
| Turnover & efficiency | |||||
| Inventory Turnover | 5.87x | 15.12x | 9.09x | 16.43x | — |
| Days Inventory Outstanding (DIO) | 62.2 | 24.1 | 40.1 | 22.2 | — |
| Receivables Turnover | 4.75x | 16.89x | 4.91x | 2.93x | — |
| Days Sales Outstanding (DSO) | 76.9 | 21.6 | 74.4 | 124.6 | — |
| Payables Turnover | 2.35x | 32.98x | 0.88x | 3.90x | — |
| Days Payable Outstanding (DPO) | 155.3 | 11.1 | 416.1 | 93.7 | — |
| Cash Conversion Cycle | -16.2 days | 34.7 days | -301.5 days | 53.1 days | — |
| Asset Turnover | 1.24x | 1.67x | 1.44x | 0.84x | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 4,396 | 4,682 | 1,515 | 1,235 | — |
| Free Cash Flow (OCF − Capex proxy) | 2,092 | 4,158 | 804 | -1,004 | — |
| Cash Conversion (OCF / EBITDA) | 89.0% | 95.4% | 86.2% | N/A | — |
| Dividends Declared | 0 | 4,248 | 179 | 300 | — |
| Dividend Payout Ratio | 0.0% | 110.3% | 136.1% | N/A | — |